Redhill Biopharma
RDHL
#10416
Rank
A$7.83 M
Marketcap
A$1.54
Share price
0.00%
Change (1 day)
-85.10%
Change (1 year)

Market capitalization of Redhill Biopharma (RDHL)

Market cap: A$7.83 Million

As of January 2026 Redhill Biopharma has a market cap of A$7.83 Million. This makes Redhill Biopharma the world's 10416th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Redhill Biopharma from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025A$8.66 M-39.08%
2024A$14.22 M-66.26%
2023A$42.16 M124.22%
2022A$18.8 M-89.92%
2021A$0.18 B-52.92%
2020A$0.39 B29.54%
2019A$0.30 B36.82%
2018A$0.22 B59.57%
2017A$0.14 B-43.42%
2016A$0.24 B10.14%
2015A$0.22 B57%
2014A$0.14 B68.02%
2013A$85.19 M
2026A$7.83 M-9.62%

End of Day market cap according to different sources

On Jan 2nd, 2026 the market cap of Redhill Biopharma was reported to be:

A$5.12 Million
by Nasdaq info icon info icon
A$7.83 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
A$174.51 B 2,227,708.02%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$397.10 B 5,069,188.96%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$150.01 B 1,914,897.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Taro Pharmaceutical
TARO
A$2.41 B 30,690.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Teva Pharmaceutical Industries
TEVA
A$53.03 B 676,882.90%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel